Elena A. C.
- Country
- Spain
- Department
- Critical Care Unit
Research Overview
Data & Insights
Has run more than one trial at 0 of 46 partner sites.
Specializations
Critical Care and Respiratory Medicine
Focused on life‑threatening pulmonary conditions and their systemic impact, especially in intensive care settings.
- Acute Respiratory Distress Syndrome
- Severe Community‑Acquired Bacterial Pneumonia
- Pulmonary Arterial Hypertension
- Combined Postcapillary and Precapillary Pulmonary Hypertension
- Heart Failure with Preserved Ejection Fraction
Research integrates advanced ventilatory strategies, hemodynamic monitoring, and targeted vasodilator therapies.
Hematologic Malignancies
Specializes in the treatment of blood‑cell cancers, emphasizing novel agents and transplantation‑free regimens.
- Multiple Myeloma
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Follicular Lymphoma
- Lymphoblastic Lymphoma
Efforts aim to improve depth of response, minimal residual disease negativity, and quality of life.
Breast Cancer Therapeutics
Addresses the full spectrum of breast malignancies, from early‑stage hormone‑responsive disease to aggressive triple‑negative forms.
- Hormone Receptor‑Positive/HER2‑Negative Early Breast Cancer
- HER2‑Positive Advanced Breast Cancer
- Triple‑Negative Breast Cancer
- Neoadjuvant and Adjuvant Treatment Strategies
- Residual Cancer Burden Assessment
The work prioritizes personalized endocrine therapies, targeted antibodies, and immune‑modulating combinations.
Genitourinary and Gynecologic Oncology
Encompasses malignancies of the prostate, bladder, kidney, ovary, and related structures, with a focus on precision medicine.
- Prostate Cancer
- Muscle‑Invasive Bladder Cancer
- Metastatic Renal Cell Carcinoma
- Ovarian Neoplasms
- Urothelial Carcinoma
Investigations explore targeted kinase inhibitors, immune checkpoint blockade, and biomarker‑driven selection.
Cardiovascular and Metabolic Disorders
Targets chronic vascular disease and metabolic risk factors that intersect with critical care and oncology.
- Atherosclerotic Cardiovascular Disease
- Hypertension
- Type 2 Diabetes
- Elevated Lipoprotein (a)
- Spontaneous Coronary Artery Dissection
Efforts include risk‑reduction strategies, novel lipid‑lowering agents, and integrated cardio‑oncology pathways.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.